Movano Inc (MOVE) Quote

Wow, December was a money maker here. Thanks Santa. Looking forward to sales coming from Android. World wide they are so many more users than with iphone ios. 2025 should see good performance and sales. Customer service is extraordinary and now free shipping, plus the addition of Dr. Wirk too as the company pivots more into the medical scene.

???? Been trading long?

so as not to give medical community false impression that the FDA approved the other sensors as well?

Re-think that statement.
Absurdity is the state or condition of being unreasonable, meaningless, or so unsound as to be irrational. "Absurd" is the adjective used to describe absurdity, e.g., "Tyler and the boys laughed at the absurd situation."[1] It derives from the Latin absurdum meaning "out of tune".[2] The Latin surdus means "deaf", implying stupidity.[1] Absurdity is contrasted with being realistic or reasonable[3] In general usage, absurdity may be synonymous with nonsense, meaninglessness, fancifulness, foolishness, bizarreness, wildness. In specialized usage, absurdity is related to extremes in bad reasoning or pointlessness in reasoning; ridiculousness is related to extremes of incongruous juxtaposition, laughter, and ridicule; and nonsense is related to a lack of meaningfulness. Absurdism is a concept in philosophy related to the notion of absurdity.

The term absurdity has been used throughout history regarding foolishness and extremely poor reasoning to form beliefs.[4] In Aristophanes' 5th century BC comedy The Wasps, his protagonist Philocleon learned the "absurdities" of Aesop's Fables, considered to be unreasonable fantasy and not real.[5] Wikipedia

https://eviering.com/products/evie-ring?_kx=rqRxv3MT2Gd6dvbqVRW0W---ss2aQ4O026nbc2LnAJ8.XWzX8R

this should boost sales even more!! https://explodingtopics.com/blog/iphone-android-users

If the O2 sensor gets approved by the FDA, could the FDA say that if the ring is used for medical use, that the other features (pulse and other sensors) would have to be stripped from the ring so as not to give medical community false impression that the FDA approved the other sensors as well?

https://eviering.com/products/evie-ring?_kx=rqRxv3MT2Gd6dvbqVRW0W---ss2aQ4O026nbc2LnAJ8.XWzX8R
Ho HO Ho... Merry Christmas

"Made with scratch resistant Liquid Metal"

$3.10
Not a positive response to the ER. Once again the reverse is hurting without news to back it up.

$3.10
Not a positive response to the ER. Once again the reverse is hurting without news to back it up.

ER is about what I expected…perhaps a bit light on units sold but no real surprises. I’m still positive especially since there are only 6 million shares outstanding after the RS.

With 6 million shares, the possibility of $1 a share earnings only requires sales of something like $25 million or 100k units. This looks like a big number but it’s only 8K a month. Approval is key to achieving these sorts of volume.

Funding will rear its head in a year or so without FDA push so dilution could be on the horizon.

These RS rarely turn out good. I am surprised they did this with out announcing something to keep the share price up.

These RS rarely turn out good. I am surprised they did this with out announcing something to keep the share price up.

RS coming. In the news.

No sign of a pulse…NB was right…it’s dead Jim!

Over on the other message board (LQMT) I’ve been trying to guess the identity of the “Tier 1 Medical Device Supplier” who participated in the last round of funding to the tune of $3 million. This is not a huge amount of money and only amounted to about 10% of the funds raised. I used the “top 10” medical device list and planned to concentrate on companies with some sort of a Boston (New England) connection since Movano Health has a joint program with MIT.

My GUESS is Phillips Healthcare (a sister division of Phillips Electronics the supplier of the RF technology). The next question is whether taking a financial position is the first step in a possible acquisition move…..ALL SPECULTION.

Maybe we can pump some life in this board……Dexcom announced a continuous glucose monitoring device today….It’s a patch that is applied to the back of the arm and it has a probe that penetrates the skin. I read a review on the CNBC website where the person testing the unit had bleeding on the first try and had to repeat the process on the other arm with a fresh device. Not exactly a perfect experience. The cost is $99/month ($89 by subscription) and is covered by most insurance plans. It communicates with a phone via Bluetooth with 15 minute updates. ..Normally needs replacement every 15 days.

Disadvantages….penetrates the skin to get a reading…subscription cost is huge …even though covered by insurance. Skillful marketing should circumvent this threat.

I guess “spell-check” has decided that when someone types “whether” …they really mean “weather” at least 88% of the time so we will protect them from being mistaken.

What could be delaying the FDA approval process?

Staffing at the FDA….work load ….vacations….

The “newness” of the RF approach doesn’t fit the established protocol……they may be concerned about the technology’s longer term accuracy and weather will continue to perform.

Asking for “more data” which is code for “our approval process is behind schedule and we need to create slack in our schedule”.

We have absolutely no control over the timing….I’ll bet a nickel they have never been early.

Earnings next Wednesday, August 14
https://finance.yahoo.com/news/movano-health-report-second-quarter-130000259.html

Everyone just waiting on news. Hurry up and wait, then wait some more.

Dead site?

First…you need money for working capital to fund growth of the business, so raising capital is good even though it comes with dilution. Also good is $3.6 million raised came from “insiders” which assesses commitment (high). Investment from a medical device whale doesn’t hurt either.

Second …If the posters would research the sensor technology, they would learn that the competitors are using infrared transmission for the pulse oximeter and Movano uses radio frequency as its technical approach…and is unique. Apple ran afoul of Masimo patents and both are using IR.

Movano has more than 30 patents for the RF sensor technology makes them an acquisition target. I hope they get the opportunity to establish the enterprise before the offer comes,,,it would be a shame to sell out at $4 when it could be worth so much more down the road.

..

Private Placement 45,000,000 $0.53 45,000,000 $23,985,000 Benchmark Insiders 2024-4-2 17:01

They had a private Placement right after news ..

Movano Health Announces $24 Million Private Placement

what an ugly MOVE, GAP& TRAP personified

glad I missed this

Buy high sell low

Why the big MOVE after hours?

Greasy lol

Boinggg

This message board is pretty good.

https://www.reddit.com/r/LQMT/s/OKyaczjzgS

Looks like everything on website, all finishes and sizes are “out of stock”

Not sure. LQMT investors are a little worried it might because of complaints about durability and scratches. Could be they sold out, but CEO publicly stated they had enough supplies on hand if there was increased demand. Some think something went wrong with the coating process. It’s anyone’s guess.

I forgot that people are hoping that Apple made them stop to buy them out and rebrand it Apple ring to compete with future Samsung ring.

I didn’t realize the Evie ring has not been available the last three weeks. Do you know why?

I only heard of MOVE by their involvement with LQMT. I am curious because LQMT had/has a relationship with Apple. With the lawsuit against Apple because of the oxygen sensor technology, it would seem that buying MOVE would be the perfect solution.

Apple also has patents for a ring device that seems similar to the Evie product. It is curious that the Evie ring has not been for sale for over 3 weeks and was wondering if Apple may have something to do with it.
.

It would seem to me once MOVE has FDA approval on their glucose monitoring chip that Apple would like to get their hands on it. Somehow. Not sure if that means MOVE keeps their women-centric Evie ring product line and sells Apple licensing rights to the chip or simply turns the whole company over and makes the Evie ring an Apple product offering, as they did with Beats by Dre and that $3B deal. Not the same since Beats was more about Apple buying the Dre name-culture-brand and in this case an acquisition by Apple of MOVE is for their tech. At which point medical grade glucose monitoring could then be incorporated into the AppleWatch and perhaps iPhone. That’s why we are invested. FDA approval of their glucose monitoring chip is a key event that they are working towards.

Any thoughts on the possibility that Apple buys MOVE to deal with outcome from Apple Watch lawsuit?

Back to back PRs. This one is starting to look good

MOVE new 52 week low

Evie ring coming in September 👍🏻

Move bought my last company Relocation.com. This company made MIllions of dollars in which Move.com will write off in Tax Dollares. This company will really MOVE once earnings are released. There going to report alot of gains. Better than EXPECTED IMO! Get in while its low.

~ Thurs-Fri $MOVE ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $MOVE ~ Earnings expected on Friday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=MOVE&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=MOVE&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=MOVE
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=MOVE#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=MOVE+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=MOVE
Finviz: http://finviz.com/quote.ashx?t=MOVE
~ BusyStock: http://busystock.com/i.php?s=MOVE&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=MOVE >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

Move, Inc. (Move) operates an online network of Websites for real estate search, finance, moving and home enthusiasts and provides a resource for consumers seeking the online information and connections they need regarding real estate. The Company’s consumer Websites are Move.com, REALTOR.com and Moving.com. It also provides lead management software for real estate agents and brokers through its Top Producer business. On the Company’s Websites it displays real estate property content, with over four million resale, new home and rental listings, as well as move-related information and tools. Move also has relationships with the real estate industry, including content agreements with approximately 900 multiple listing services (MLS) across the United States and partnerships with the National Association of REALTORS (NAR) and the National Association of Home Builders (NAHB). On June 22, 2009, it divested its interest in Welcome Wagon business. In July2011, the Company acquired SocialBios.

http://www.google.com/finance?q=MOVE